Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
biodefense (36) 36
animals (30) 30
humans (26) 26
index medicus (23) 23
immunology (20) 20
mice (15) 15
vaccines (13) 13
toxin (10) 10
article (9) 9
biological weapons (9) 9
bioterrorism (9) 9
medicine, research & experimental (9) 9
proteins (9) 9
biodefence (7) 7
female (7) 7
monoclonal antibodies (7) 7
pharmacology & pharmacy (7) 7
vaccine (7) 7
allergy and immunology (6) 6
amino acid sequence (6) 6
antibody (6) 6
health aspects (6) 6
mice, inbred balb c (6) 6
molecular sequence data (6) 6
a-chain (5) 5
biological warfare (5) 5
biotechnology & applied microbiology (5) 5
identification (5) 5
lectins (5) 5
neutralization tests (5) 5
ricin - immunology (5) 5
antibodies, neutralizing - immunology (4) 4
antiviral agents (4) 4
bacillus-anthracis (4) 4
biological warfare agents (4) 4
immunity (4) 4
immunoglobulins (4) 4
infection (4) 4
neutralizing (4) 4
poisoning - prevention & control (4) 4
protection (4) 4
ricin - toxicity (4) 4
toxins (4) 4
virology (4) 4
viruses (4) 4
analysis (3) 3
anthrax (3) 3
antigenic determinants (3) 3
antigens (3) 3
binding (3) 3
biochemistry & molecular biology (3) 3
bioterrorism - prevention & control (3) 3
cytotoxicity (3) 3
epidemiology (3) 3
epitopes (3) 3
equine encephalitis-virus (3) 3
expressed sequence tags (3) 3
immune-responses (3) 3
infectious diseases (3) 3
leukocytes (3) 3
monoclonal-antibodies (3) 3
mycobacterium-tuberculosis (3) 3
peptides (3) 3
prevention (3) 3
proteomics (3) 3
ricin - antagonists & inhibitors (3) 3
smallpox (3) 3
therapeutic (3) 3
vaccination - methods (3) 3
vaccines - immunology (3) 3
vaccines, subunit - immunology (3) 3
veterinary sciences (3) 3
virus diseases (3) 3
aerosols (2) 2
amino acids (2) 2
animal diseases (2) 2
anthrax toxin (2) 2
antibodies (2) 2
antibodies, monoclonal - immunology (2) 2
antibodies, neutralizing - therapeutic use (2) 2
antibodies, viral - immunology (2) 2
antibody specificity (2) 2
antigens, bacterial - genetics (2) 2
antigens, bacterial - immunology (2) 2
apoptosis (2) 2
bacterial toxins - immunology (2) 2
bacterial toxins - toxicity (2) 2
bacterial vaccines - immunology (2) 2
base sequence (2) 2
biochemical research methods (2) 2
biological response modifiers (2) 2
biomarkers (2) 2
biosensor (2) 2
cdna library (2) 2
cell culture (2) 2
cell line (2) 2
cercopithecus aethiops (2) 2
challenge (2) 2
communicable diseases, emerging - epidemiology (2) 2
competition (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Biodefense properties of milk: The role of antimicrobial proteins and peptides
by Clare, D.A and Catignani, G.L and Swaisgood, H.E
Current Pharmaceutical Design, ISSN 1381-6128, 2003, Volume 9, Issue 16, pp. 1239 - 1255
Mammary fluids colostrum and milk, deliver nature's first host defense systems upon birth, and these essential liquids are critical for survival of the... 
Antimicrobial milk proteins | Antimicrobial milk peptides | Biodefense proteins and peptides | Review article | Immunoregulatory milk peptides | Immunoregulatory milk proteins | LACTOFERRIN-RELATED COMPOUNDS | review article | AFFINITY MASS-SPECTROMETRY | BOVINE KAPPA-CASEIN | antimicrobial milk proteins | immunoregulatory milk proteins | antimicrobial milk peptides | biodefense proteins and peptides | TOXIGENIC ESCHERICHIA-COLI | AMINO-ACID-SEQUENCE | immunoregulatory milk peptides | LACTOPEROXIDASE SYSTEM | BACTERICIDAL ACTIVITY | ANTIBACTERIAL ACTIVITY | PHARMACOLOGY & PHARMACY | ALPHA-LACTALBUMIN | N-TERMINAL REGION | Milk - chemistry | Adjuvants, Immunologic - pharmacology | Peptides | Humans | Milk, Human - chemistry | Colostrum - immunology | Animals | Milk Proteins - chemistry | Milk Proteins - immunology | Adjuvants, Immunologic - chemistry | Anti-Bacterial Agents - chemistry | Milk Proteins - pharmacology | Anti-Bacterial Agents - pharmacology | Milk - immunology | Milk, Human - immunology | Colostrum - chemistry
Journal Article
Details down arrow
2. Full Text Gene expression in haemocytes of kuruma prawn, Penaeus japonicus, in response to infection with WSSV by EST approach
by Rojtinnakorn, Jiraporn and Hirono, Ikuo and Itami, Toshiaki and Takahashi, Yukinori and Aoki, Takashi
Fish and Shellfish Immunology, ISSN 1050-4648, 07/2002, Volume 13, Issue 1, pp. 69 - 83
Gene expression in haemocytes of the kuruma prawn (Penaeus japonicus) was investigated using an expressed sequence tag (EST) approach. Partial nucleotide... 
expressed sequence tags (ESTs), Penaeus japonicus, biodefence, haemocytes, white spot syndrome virus (WSSV), viral infection | Biodefence | Penaeus japonicus | Expressed sequence tags (ESTs) | Viral infection | White spot syndrome virus (WSSV) | Haemocytes | SYSTEM | CELLS | PHAGOCYTOSIS | viral infection | SEQUENCES | haemocytes | HOMOLOG | IMMUNOLOGY | expressed sequence tags (ESTs) | biodefence | white spot syndrome virus (WSSV) | SHRIMP | FISHERIES | LEUKOCYTES | MARINE & FRESHWATER BIOLOGY | VETERINARY SCIENCES | VIRAL DISEASES | SHAPED DNA VIRUS | MONODON | Amino Acid Sequence | Penaeidae - virology | Gene Library | Peptides - chemistry | Hemocytes - immunology | Peptides - immunology | Molecular Sequence Data | DNA Viruses - genetics | Hemocytes - virology | Sequence Homology | Animals | Gene Expression Regulation, Viral | Base Sequence | Sequence Analysis, DNA - veterinary | Expressed Sequence Tags | Penaeidae - immunology | Virus diseases | Biological weapons | Protease inhibitors | Proteases | Aquaporins | Gene expression | Health aspects | Lysozyme | Integrins | Expressed sequence tags
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB)
by Yermakova, Anastasiya and Mantis, Nicholas J
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 45, pp. 7925 - 7935
Highlights â–º We have produced and characterized a collection of RTB-specific murine monoclonal antibodies (mAbs). â–º We have demonstrated that two RTB-specific... 
Allergy and Immunology | Biodefense | Toxin | Vaccine | Epitope | Immunity | Neutralizing | MEDICINE, RESEARCH & EXPERIMENTAL | B-CHAIN | SITE | MECHANISM | CYTOLETHAL DISTENDING TOXIN | A-CHAIN | GALACTOSE-BINDING | MONOCLONAL-ANTIBODY | IMMUNOLOGY | IDENTIFICATION | HYPOGLYCEMIA | MICE | Antitoxins - immunology | Epitope Mapping | Antitoxins - blood | Neutralization Tests | Poisoning - prevention & control | Hypoglycemia - prevention & control | Antitoxins - therapeutic use | Antibodies, Neutralizing - immunology | Poisoning - immunology | Antibodies, Neutralizing - therapeutic use | Female | Ricin - antagonists & inhibitors | Hypoglycemia - chemically induced | Immunization, Passive - methods | Immunization - methods | Models, Molecular | Blood Glucose | Vaccines, Subunit - immunology | Poisoning - pathology | Ricin - immunology | Animals | Vaccines, Subunit - administration & dosage | Survival Analysis | Mice | Mice, Inbred BALB C | Antibodies, Neutralizing - blood | Poisoning - mortality | Monoclonal antibodies | Lectins | Biological weapons | Antigenic determinants | Proteins | Competition | Cell culture | Lactose | Peptides | Cytotoxicity | Protein expression | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text NIAID resources for developing new therapies for severe viral infections
by Greenstone, Heather and Spinelli, Beth and Tseng, Christopher and Peacock, Susan and Taylor, Katherine and Laughlin, Catherine
Antiviral Research, ISSN 0166-3542, 2008, Volume 78, Issue 1, pp. 51 - 59
Severe viral infections, including hemorrhagic fever and encephalitis, occur throughout the world, but are most prevalent in developing areas that are most... 
Junin | Human herpes virus 8 | Medicinal chemistry | Phase I clinical trials | Pichinde | Pharmacodynamic | Antiviral testing program | Recombinant proteins | Cloned genes | Papillomaviruses | Formulation | Epstein-Barr virus | Synthesis/resynthesis | Synthetic peptides | Hepatitis B virus | Immunomodulatory | Chemical synthesis | Human herpes virus 6 | Yellow fever | Rift valley fever | Influenza type A | BK virus | Nucleic acids | Cationic lipid–DNA complexes (CLDC) | Pharmacokinetic | Biodefense and emerging infections repository | BEIR | Intellectual property option (IP option) | BLA | Monoclonal antibodies | Anti-inflammatory | IND | Determination of exceptional circumstances (DEC) | Juvaris BioTherapeutics | Highly pathogenic RNA viruses | West nile | NDA | Avian H5N1 | Patent protection | Severe acute respiratory syndrome (SARS)-associated coronavirus | Herpes simplex type 1 and type 2 | Rhinoviruses | Measles | Venezuelan equine encephalitis | Manufacturing | Orthopoxviruses | Clinical evaluations | Parainfluenza | NIAID Category A, B and C | Cytomegalovirus | Screening agreement | Dengue | Varicella-Zoster virus | Radiolabeled compounds | NIAID | Hamster-scrapie | Western equine encephalitis viruses | Vaccinia virus | In vivo testing submission form | Services for the preclinical development of therapeutic agents | Lassa fever | Respiratory syncytial virus | HIV | Adenoviruses | Filoviruses | Intellectual property | Hepatitis C virus | Cowpox virus | Tacaribe | BSL-4 containment | Cationic lipid-DNA complexes (CLDC) | cowpox virus | hepatitis B virus | lassa fever | N-METHANOCARBATHYMIDINE | venezuelan equine encephalitis | screening agreement | parainfluenza | cytomegalovirus | orthopoxviruses | western equine encephalitis viruses | formulation | manufacturing | PHARMACOLOGY & PHARMACY | synthesis/resynthesis | avian H5N1 | human herpes virus 6 | highly pathogenic RNA viruses | NIAID category A | antiviral testing program | nucleic acids | filoviruses | phase I clinical trials | ETHER LIPID ESTERS | varicella-zoster virus | intellectual property | juvaris BioTherapeutics | in vivo testing submission form | synthetic peptides | pharmacodynamic | respiratory syncytial virus | west nile | human herpes virus 8 | immunomodulatory | influenza type A | services for the preclinical development of therapeutic agents | rift valley fever | yellow fever | HAMSTER MODEL | COTTON RATS | vaccinia virus | papillomaviruses | VIROLOGY | determination of exceptional circumstances (DEC) | intellectual property option (IP option) | anti-inflammatory | hepatitis C virus | adenoviruses | B and C | pharmacokinetic | IN-VIVO ACTIVITIES | medicinal chemistry | LETHAL MOUSEPOX MODEL | severe acute respiratory syndrome (SARS)-associated | WEST-NILE-VIRUS | recombinant proteins | herpes simplex type 1 and type 2 | patent protection | coronavirus | CYTOMEGALOVIRUS-INFECTION | dengue | cloned genes | ORTHOPOXVIRUS INFECTIONS | chemical synthesis | cationic lipid-DNA complexes (CLDC) | clinical evaluations | biodefense and emerging infections repository | measles | radiolabeled compounds | hamster-scrapie | monoclonal antibodies | Private Sector | Severity of Illness Index | Cricetinae | Antiviral Agents - therapeutic use | United States | Humans | Research Support as Topic | Biotechnology - methods | Program Development | Animals | Virus Diseases - drug therapy | Virus Diseases - physiopathology | Dogs | Mice | National Institute of Allergy and Infectious Diseases (U.S.) | Drug Evaluation, Preclinical | Antiviral agents | Peptides | RNA | Avian influenza viruses | Development and progression | Hamsters | Case studies | Avian influenza | Rift Valley fever | Ebola virus infections | Product development | Hepatitis C | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Human neutralizing antibodies against MERS coronavirus: Implications for future immunotherapy
by Tang, Xian-Chun and Marasco, Wayne A
Immunotherapy, ISSN 1750-743X, 07/2015, Volume 7, Issue 6, pp. 591 - 594
  The high mortality rate ( 37%) and ongoing epidemic have raised concern of a more widespread regional outbreak or even global spread. Since this virus was... 
humoral immunity | spike protein | MERS-CoV | IGHV1-69 | animal model | human monoclonal antibodies | passive immunotherapy | zoonosis | biodefense | emerging pathogen | COV | IMMUNOLOGY | EAST RESPIRATORY SYNDROME | INFECTION | RHESUS MACAQUES | Antibodies, Neutralizing - immunology | Antibodies, Viral - therapeutic use | Antibodies, Neutralizing - therapeutic use | Coronavirus Infections - therapy | Humans | Immunotherapy | Portraits as Topic | Antibodies, Viral - immunology | Coronavirus Infections - immunology | Middle East Respiratory Syndrome Coronavirus - immunology | Competition | Antigens | Cell culture | Immunoglobulins | Mortality | Animal diseases | Infections | Proteins | Studies | Libraries | Mutation | Laboratory animals | Viral infections
Journal Article
Details down arrow
6. Full Text BEI Resources: Supporting antiviral research
by Baker, Robert and Peacock, Susan
Antiviral Research, ISSN 0166-3542, 2008, Volume 80, Issue 2, pp. 102 - 106
The Biodefense and Emerging Infections Research Resources Repository (BEI Resources) provides unique, quality-assured reagents to the scientific community for... 
Biodefense | Repository | Antiviral therapy | Emerging infectious disease | Culture collection | Reagents | VIROLOGY | PHARMACOLOGY & PHARMACY | Communicable Diseases, Emerging | Antiviral Agents - supply & distribution | Containment of Biohazards | Research Support as Topic - standards | Bioterrorism | Antiviral Agents - standards | Biomedical Research - standards | Quality Control | Monoclonal antibodies | Antiviral agents | emerging infectious disease | culture collection | repository | reagents | biodefense | antiviral therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Mechanisms of ricin toxin neutralization revealed through engineered homodimeric and heterodimeric camelid antibodies
by Herrera, Cristina and Tremblay, Jacqueline M and Shoemaker, Charles B and Mantis, Nicholas J
Journal of Biological Chemistry, ISSN 0021-9258, 11/2015, Volume 290, Issue 46, pp. 27880 - 27889
Novel antibody constructs consisting of two or more different camelid heavy-chain only antibodies (VHHs) joined via peptide linkers have proven to have potent... 
PASSIVELY PROTECTS MICE | CHAIN | CHALLENGE | IMMUNITY | POLIOVIRUS | NANOBODIES | AFFINITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTHRAX TOXIN | LECTINS | BINDING | Protein Multimerization | Cercopithecus aethiops | Immunoglobulin Heavy Chains - chemistry | Ultracentrifugation | Ricin - immunology | Antibodies, Neutralizing - immunology | Animals | Antibodies, Neutralizing - chemistry | Camelids, New World - immunology | Protein Engineering | Inhibitory Concentration 50 | Female | Mice | Mice, Inbred BALB C | Ricin - antagonists & inhibitors | Immunoglobulin Heavy Chains - immunology | Vero Cells | antibody engineering | single-domain antibody (sdAb,nanobody) | therapeutic | mouse | Immunology | toxin | ricin | neutralizing | biodefense
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Peptidoglycan inducible expression of a serine proteinase homologue from kuruma shrimp ( Marsupenaeus japonicus)
by Rattanachai, Achara and Hirono, Ikuo and Ohira, Tsuyoshi and Takahashi, Yukinori and Aoki, Takashi
Fish and Shellfish Immunology, ISSN 1050-4648, 2005, Volume 18, Issue 1, pp. 39 - 48
A cDNA encoding a serine proteinase homologue of kuruma shrimp (Marsupenaeus japonicus) was cloned. The 1257 bp cDNA encodes a 339 amino acid putative peptide,... 
Biodefence | Peptidoglycan | Crustaceans | Serine proteinase homologue | Marsupenaeus japonicus | CRAYFISH PACIFASTACUS-LENIUSCULUS | MANDUCA-SEXTA | MASQUERADE | ACTIVATION | crustaceans | PATTERN-RECOGNITION PROTEIN | IMMUNOLOGY | biodefence | INVERTEBRATE IMMUNITY | FRESH-WATER CRAYFISH | peptidoglycan | PENAEUS-JAPONICUS | FISHERIES | HEMOCYTES | MARINE & FRESHWATER BIOLOGY | VETERINARY SCIENCES | MOLECULAR-CLONING | serine proteinase homologue | Peptidoglycan - metabolism | Amino Acid Sequence | Penaeidae - genetics | DNA, Complementary - genetics | Molecular Sequence Data | DNA Primers | Hemocytes - metabolism | Sequence Analysis, DNA | Gene Expression Regulation, Enzymologic | Sequence Homology | Blotting, Northern | Sequence Alignment | Animals | Base Sequence | Serine Endopeptidases - genetics | Penaeidae - metabolism | Serine Endopeptidases - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Chimpanzee/Human mAbs to Vaccinia Virus B5 Protein Neutralize Vaccinia and Smallpox Viruses and Protect Mice against Vaccinia Virus
by Zhaochun Chen and Patricia Earl and Jeffrey Americo and Inger Damon and Scott K. Smith and Yi-Hua Zhou and Fujuan Yu and Andrew Sebrell and Suzanne Emerson and Gary Cohen and Roselyn J. Eisenberg and Juraj Svitel and Peter Schuck and William Satterfield and Bernard Moss and Robert Purcell
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2006, Volume 103, Issue 6, pp. 1882 - 1887
Chimpanzee Fabs against the B5 envelope glycoprotein of vaccinia virus were isolated and converted into complete mAbs with human heavy chain constant regions.... 
Proteins | Smallpox | Variola virus | Weight loss | Antibodies | Viruses | Amino acids | Epitopes | Dosage | Vaccinia | Biodefense | GENE | MEMBRANE | MULTIDISCIPLINARY SCIENCES | DISSEMINATION | TO-CELL SPREAD | IMMUNE GLOBULIN | VACCINATION | PHAGE DISPLAY | EXTRACELLULAR ENVELOPED VIRUS | GLYCOPROTEIN | MONOCLONAL-ANTIBODIES | biodefense | Amino Acid Sequence | Vaccinia virus - pathogenicity | Variola virus - immunology | Viral Proteins - chemistry | Humans | Viral Proteins - immunology | Molecular Sequence Data | Neutralization Tests | Immunoglobulin Fab Fragments - isolation & purification | Antibodies, Monoclonal - isolation & purification | Pan troglodytes - immunology | Vaccinia virus - immunology | Epitopes - immunology | Vaccinia - prevention & control | Animals | Vaccinia virus - chemistry | Vaccinia - immunology | Female | Mice | Immunoglobulin Fab Fragments - immunology | Antibodies, Monoclonal - immunology | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Ebolavirus and Marburgvirus: Insight the Filoviridae family
by Ascenzi, Paolo and Bocedi, Alessio and Heptonstall, Julia and Capobianchi, Maria Rosaria and Di Caro, Antonino and Mastrangelo, Eloise and Bolognesi, Martino and Ippolito, Giuseppe
Molecular Aspects of Medicine, ISSN 0098-2997, 2008, Volume 29, Issue 3, pp. 151 - 185
Ebolavirus and Marburgvirus (belonging to the family) emerged four decades ago and cause epidemics of haemorrhagic fever with high case-fatality rates. The... 
Ebolavirus | Therapy | Clinical features and management | Prevention and control | Viral genome | Pathogenesis | Vaccine | Epidemiology | Infection | Biodefence | Viral proteins | Lethal haemorrhagic fever | Marburgvirus | MEDICINE, RESEARCH & EXPERIMENTAL | infection | DOUBLE-STRANDED-RNA | DEPENDENT RNA-POLYMERASE | EQUINE ENCEPHALITIS-VIRUS | MATRIX PROTEIN | ENVELOPE GLYCOPROTEIN | clinical features and management | epidemiology | viral genome | therapy | BIOCHEMISTRY & MOLECULAR BIOLOGY | VP35 PROTEIN | LATE BUDDING DOMAINS | viral proteins | biodefence | pathogenesis | vaccine | HEMORRHAGIC-FEVER | VIRUS-LIKE PARTICLES | PROTECT GUINEA-PIGS | prevention and control | lethal haemorrhagic fever | Ebolavirus - metabolism | Marburgvirus - physiology | Humans | Filoviridae Infections - therapy | Virus Assembly | Ebolavirus - chemistry | Biological Warfare Agents | Animals | Filoviridae Infections - prevention & control | Marburgvirus - chemistry | Filoviridae Infections - pathology | Ebolavirus - physiology | Marburgvirus - metabolism | Viral Vaccines - immunology | Proteins | Epidemics | Hemorrhagic fever | Biological weapons | RNA | Genomics | Reservoirs | Biological response modifiers | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Folding domains within the ricin toxin A subunit as targets of protective antibodies
by O’Hara, Joanne M and Neal, Lori M and McCarthy, Elizabeth A and Kasten-Jolly, Jane A and Brey, Robert N and Mantis, Nicholas J
Vaccine, ISSN 0264-410X, 2010, Volume 28, Issue 43, pp. 7035 - 7046
Abstract Efforts to develop an effective vaccine against ricin are focused on the engineering of attenuated and stable recombinant forms of the toxin's... 
Allergy and Immunology | Biodefense | Toxin | Mouse | Antibody | Immunity | MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN VACCINE | SPECIFICITY | A-CHAIN | DETERMINANTS | STABILITY | TOXICITY | IMMUNOLOGY | PREDICTION | MONOCLONAL-ANTIBODIES | BINDING | NEUTRALIZATION | Immunodominant Epitopes - immunology | Epitope Mapping | Rabbits | Protein Structure, Secondary | Antibodies, Monoclonal - biosynthesis | Cercopithecus aethiops | Models, Molecular | Antibody Affinity | Epitopes, B-Lymphocyte - immunology | Protein Folding | Ricin - immunology | Antibodies, Neutralizing - immunology | Animals | Ricin - chemistry | Female | Mice | Mice, Inbred BALB C | Vero Cells | Antibodies, Monoclonal - immunology | Monoclonal antibodies | Enzymes | Biological weapons | Antigenic determinants | Proteins | Studies | Petroleum production | Cytotoxicity | Mutation | Vaccines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit
by O’Hara, Joanne M and Whaley, Kevin and Pauly, Michael and Zeitlin, Larry and Mantis, Nicholas J
Vaccine, ISSN 0264-410X, 2011, Volume 30, Issue 7, pp. 1239 - 1243
Highlights â–º GD12 is a murine monoclonal antibody that protects mice from ricin toxin. â–º A partially humanized version of GD12 was produced in plants. â–º... 
Allergy and Immunology | Biodefense | Toxin | Antibody | Therapeutics | ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | A-CHAIN | HYPOGLYCEMIA | MODEL | IMMUNOLOGY | IDENTIFICATION | Antibodies, Neutralizing - administration & dosage | Humans | Molecular Sequence Data | Poisoning - prevention & control | Antibodies, Monoclonal, Humanized - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Immunoglobulin G - immunology | Antibodies, Monoclonal, Humanized - biosynthesis | Female | Recombinant Fusion Proteins - administration & dosage | Recombinant Fusion Proteins - biosynthesis | Amino Acid Sequence | Gene Expression | Tobacco - metabolism | Immunoglobulin G - chemistry | Injections, Intraperitoneal | Antibodies, Neutralizing - genetics | Epitopes | Ricin - toxicity | Ricin - immunology | Animals | Antibodies, Neutralizing - biosynthesis | Tobacco - genetics | Immunization, Passive | Recombinant Fusion Proteins - genetics | Mice | Mice, Inbred BALB C | Immunodominant Epitopes | Monoclonal antibodies | Lectins | Biological weapons | Immunoglobulin G | Antigenic determinants | Proteins | Medical research | Cytotoxicity | Amino acids | Rodents | therapeutics | antibody | toxin | biodefense
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Japanese encephalitis
: The virus and vaccines
by Yun, Sang-Im and Lee, Young-Min
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 02/2014, Volume 10, Issue 2, pp. 263 - 279
Japanese encephalitis (JE) is an infectious disease of the central nervous system caused by Japanese encephalitis virus (JEV), a zoonotic mosquito-borne... 
pathogenesis | vaccine | virulence | immunization | Japanese encephalitis virus | biodefense | prevention | flavivirus | NEUTRALIZING ANTIBODY | WEST-NILE-VIRUS | ENVELOPE PROTEIN | IMMUNOLOGY | NONSTRUCTURAL PROTEIN NS2A | CYTOTOXIC T-LYMPHOCYTES | PROTECTIVE IMMUNITY | DENGUE-VIRUS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ACUTE DISSEMINATED ENCEPHALOMYELITIS | YELLOW-FEVER VIRUS | LONG-TERM IMMUNITY | Japanese Encephalitis Vaccines - administration & dosage | Cell Line | Encephalitis, Japanese - virology | Humans | Japanese Encephalitis Vaccines - immunology | Drug Discovery - trends | Technology, Pharmaceutical - methods | Asia - epidemiology | Animals | Encephalitis, Japanese - epidemiology | Vaccination - methods | Encephalitis, Japanese - prevention & control | Encephalitis Virus, Japanese - immunology | Japanese Encephalitis Vaccines - isolation & purification | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights